Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

Protective Role of Postbiotic Mediators Secreted by Lactobacillus rhamnosus GG Versus Lipopolysaccharide-induced Damage in Human Colonic Smooth Muscle Cells.

Cicenia A, Santangelo F, Gambardella L, Pallotta L, Iebba V, Scirocco A, Marignani M, Tellan G, Carabotti M, Corazziari ES, Schippa S, Severi C.

J Clin Gastroenterol. 2016 Nov/Dec;50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015:S140-S144.

PMID:
27741159
2.

Gut microbiota related to Giardia duodenalis, Entamoeba spp. and Blastocystis hominis infections in humans from Côte d'Ivoire.

Iebba V, Santangelo F, Totino V, Pantanella F, Monsia A, Di Cristanziano V, Di Cave D, Schippa S, Berrilli F, D'Alfonso R.

J Infect Dev Ctries. 2016 Sep 30;10(9):1035-1041. doi: 10.3855/jidc.8179.

3.

Hyaluronan-cholesterol nanohydrogels: Characterisation and effectiveness in carrying alginate lyase.

Montanari E, Di Meo C, Sennato S, Francioso A, Marinelli AL, Ranzo F, Schippa S, Coviello T, Bordi F, Matricardi P.

N Biotechnol. 2016 Aug 26. pii: S1871-6784(16)32385-8. doi: 10.1016/j.nbt.2016.08.004. [Epub ahead of print]

PMID:
27576102
4.

Eubiosis and dysbiosis: the two sides of the microbiota.

Iebba V, Totino V, Gagliardi A, Santangelo F, Cacciotti F, Trancassini M, Mancini C, Cicerone C, Corazziari E, Pantanella F, Schippa S.

New Microbiol. 2016 Jan;39(1):1-12. Review.

5.

Exposure of E. coli to DNA-Methylating Agents Impairs Biofilm Formation and Invasion of Eukaryotic Cells via Down Regulation of the N-Acetylneuraminate Lyase NanA.

Di Pasquale P, Caterino M, Di Somma A, Squillace M, Rossi E, Landini P, Iebba V, Schippa S, Papa R, Selan L, Artini M, Palamara AT, Duilio A.

Front Microbiol. 2016 Feb 11;7:147. doi: 10.3389/fmicb.2016.00147. Erratum in: Front Microbiol. 2016;7:383. Palamara, Annateresa [corrected to Palamara, Anna Teresa]. Front Microbiol. 2016;7:383.

6.

Bacterial Biofilm in Salivary Gland Stones: Cause or Consequence?

Fusconi M, Petrozza V, Schippa S, de Vincentiis M, Familiari G, Pantanella F, Cirenza M, Iebba V, Battaglione E, Greco A, Gallipoli C, Campo F, Gallo A.

Otolaryngol Head Neck Surg. 2016 Mar;154(3):449-53. doi: 10.1177/0194599815622425.

PMID:
26759424
7.

Violacein, an indole-derived purple-colored natural pigment produced by Janthinobacterium lividum, inhibits the growth of head and neck carcinoma cell lines both in vitro and in vivo.

Masuelli L, Pantanella F, La Regina G, Benvenuto M, Fantini M, Mattera R, Di Stefano E, Mattei M, Silvestri R, Schippa S, Manzari V, Modesti A, Bei R.

Tumour Biol. 2016 Mar;37(3):3705-17. doi: 10.1007/s13277-015-4207-3.

PMID:
26462840
8.

Influenza A virus infection of intestinal epithelial cells enhances the adhesion ability of Crohn's disease associated Escherichia coli strains.

Aleandri M, Conte MP, Simonetti G, Panella S, Celestino I, Checconi P, Marazzato M, Longhi C, Goldoni P, Nicoletti M, Barnich N, Palamara AT, Schippa S, Nencioni L.

PLoS One. 2015 Feb 23;10(2):e0117005. doi: 10.1371/journal.pone.0117005.

9.

Dysbiotic events in gut microbiota: impact on human health.

Schippa S, Conte MP.

Nutrients. 2014 Dec 11;6(12):5786-805. doi: 10.3390/nu6125786. Review.

10.

Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.

Giannelli V, Di Gregorio V, Iebba V, Giusto M, Schippa S, Merli M, Thalheimer U.

World J Gastroenterol. 2014 Dec 7;20(45):16795-810. doi: 10.3748/wjg.v20.i45.16795. Review.

11.

The Shigella flexneri OspB effector: an early immunomodulator.

Ambrosi C, Pompili M, Scribano D, Limongi D, Petrucca A, Cannavacciuolo S, Schippa S, Zagaglia C, Grossi M, Nicoletti M.

Int J Med Microbiol. 2015 Jan;305(1):75-84. doi: 10.1016/j.ijmm.2014.11.004.

PMID:
25434600
12.

Adherent-invasive Escherichia coli (AIEC) in pediatric Crohn's disease patients: phenotypic and genetic pathogenic features.

Conte MP, Longhi C, Marazzato M, Conte AL, Aleandri M, Lepanto MS, Zagaglia C, Nicoletti M, Aloi M, Totino V, Palamara AT, Schippa S.

BMC Res Notes. 2014 Oct 22;7:748. doi: 10.1186/1756-0500-7-748.

13.

Bdellovibrio bacteriovorus directly attacks Pseudomonas aeruginosa and Staphylococcus aureus Cystic fibrosis isolates.

Iebba V, Totino V, Santangelo F, Gagliardi A, Ciotoli L, Virga A, Ambrosi C, Pompili M, De Biase RV, Selan L, Artini M, Pantanella F, Mura F, Passariello C, Nicoletti M, Nencioni L, Trancassini M, Quattrucci S, Schippa S.

Front Microbiol. 2014 Jun 5;5:280. doi: 10.3389/fmicb.2014.00280.

14.

Outbreak of Achromobacter xylosoxidans in an Italian Cystic fibrosis center: genome variability, biofilm production, antibiotic resistance, and motility in isolated strains.

Trancassini M, Iebba V, Citerà N, Tuccio V, Magni A, Varesi P, De Biase RV, Totino V, Santangelo F, Gagliardi A, Schippa S.

Front Microbiol. 2014 Apr 3;5:138. doi: 10.3389/fmicb.2014.00138.

15.

Higher prevalence and abundance of Bdellovibrio bacteriovorus in the human gut of healthy subjects.

Iebba V, Santangelo F, Totino V, Nicoletti M, Gagliardi A, De Biase RV, Cucchiara S, Nencioni L, Conte MP, Schippa S.

PLoS One. 2013 Apr 16;8(4):e61608. doi: 10.1371/journal.pone.0061608. Erratum in: PLoS One. 2013;8(7). doi:10.1371/annotation/b08ddcc9-dfdb-4fc1-b2ac-5a4af3051a91.

16.

Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.

Schippa S, Iebba V, Santangelo F, Gagliardi A, De Biase RV, Stamato A, Bertasi S, Lucarelli M, Conte MP, Quattrucci S.

PLoS One. 2013 Apr 17;8(4):e61176. doi: 10.1371/journal.pone.0061176. Erratum in: PLoS One. 2013;8(7). doi:10.1371/annotation/a8b06cd3-c8a8-48fa-9748-b04fded4b963.

17.

Gut microbiota and the immune system: an intimate partnership in health and disease.

Iebba V, Nicoletti M, Schippa S.

Int J Immunopathol Pharmacol. 2012 Oct-Dec;25(4):823-33. Review.

PMID:
23298474
18.

A potential role of Escherichia coli pathobionts in the pathogenesis of pediatric inflammatory bowel disease.

Schippa S, Iebba V, Totino V, Santangelo F, Lepanto M, Alessandri C, Nuti F, Viola F, Di Nardo G, Cucchiara S, Longhi C, Conte MP.

Can J Microbiol. 2012 Apr;58(4):426-32. doi: 10.1139/w2012-007.

PMID:
22439600
19.

Microevolution in fimH gene of mucosa-associated Escherichia coli strains isolated from pediatric patients with inflammatory bowel disease.

Iebba V, Conte MP, Lepanto MS, Di Nardo G, Santangelo F, Aloi M, Totino V, Checchi MP, Longhi C, Cucchiara S, Schippa S.

Infect Immun. 2012 Apr;80(4):1408-17. doi: 10.1128/IAI.06181-11.

20.

Plasmid-mediated fluoroquinolone resistance determinants in Escherichia coli from community uncomplicated urinary tract infection in an area of high prevalence of quinolone resistance.

Longhi C, Conte MP, Marazzato M, Iebba V, Totino V, Santangelo F, Gallinelli C, Pallecchi L, Riccobono E, Schippa S, Comanducci A.

Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):1917-21. doi: 10.1007/s10096-011-1521-6.

PMID:
22210265
Items per page

Supplemental Content

Loading ...
Support Center